Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

Hannah G. Rosenblum(Epidemic Intelligence Service), Julianne Gee(Centers for Disease Control and Prevention), Ruiling Liu(Centers for Disease Control and Prevention), Paige Marquez(Centers for Disease Control and Prevention), Bicheng Zhang(Centers for Disease Control and Prevention), Penelope Strid(Centers for Disease Control and Prevention), Winston E. Abara(Centers for Disease Control and Prevention), Michael M. McNeil(Centers for Disease Control and Prevention), Tanya R. Myers(Centers for Disease Control and Prevention), Anne M. Hause(Centers for Disease Control and Prevention), John R. Su(Centers for Disease Control and Prevention), Lauri E. Markowitz(Centers for Disease Control and Prevention), Tom T. Shimabukuro(Centers for Disease Control and Prevention), David K. Shay(Centers for Disease Control and Prevention)
The Lancet Infectious Diseases
March 7, 2022
Cited by 182Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis